Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1993 1
1994 3
1995 3
1996 1
1997 1
1998 5
1999 3
2000 4
2001 6
2002 6
2003 5
2004 8
2005 6
2006 10
2007 13
2008 10
2009 11
2010 13
2011 11
2012 22
2013 19
2014 24
2015 18
2016 19
2017 10
2018 25
2019 31
2020 26
2021 20
2022 13
2023 17
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

314 results

Results by year

Filters applied: . Clear all
Page 1
Genome-wide cell-free DNA fragmentation in patients with cancer.
Cristiano S, Leal A, Phallen J, Fiksel J, Adleff V, Bruhm DC, Jensen SØ, Medina JE, Hruban C, White JR, Palsgrove DN, Niknafs N, Anagnostou V, Forde P, Naidoo J, Marrone K, Brahmer J, Woodward BD, Husain H, van Rooijen KL, Ørntoft MW, Madsen AH, van de Velde CJH, Verheij M, Cats A, Punt CJA, Vink GR, van Grieken NCT, Koopman M, Fijneman RJA, Johansen JS, Nielsen HJ, Meijer GA, Andersen CL, Scharpf RB, Velculescu VE. Cristiano S, et al. Among authors: verheij m. Nature. 2019 Jun;570(7761):385-389. doi: 10.1038/s41586-019-1272-6. Epub 2019 May 29. Nature. 2019. PMID: 31142840 Free PMC article.
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.
Cats A, Jansen EPM, van Grieken NCT, Sikorska K, Lind P, Nordsmark M, Meershoek-Klein Kranenbarg E, Boot H, Trip AK, Swellengrebel HAM, van Laarhoven HWM, Putter H, van Sandick JW, van Berge Henegouwen MI, Hartgrink HH, van Tinteren H, van de Velde CJH, Verheij M; CRITICS investigators. Cats A, et al. Among authors: verheij m. Lancet Oncol. 2018 May;19(5):616-628. doi: 10.1016/S1470-2045(18)30132-3. Epub 2018 Apr 9. Lancet Oncol. 2018. PMID: 29650363 Clinical Trial.
[18F]FDG-PET-Based Personalized Radiotherapy Dose Prescription.
Kaanders JHAM, Bussink J, Aarntzen EHJG, Braam P, Rütten H, van der Maazen RWM, Verheij M, van den Bosch S. Kaanders JHAM, et al. Among authors: verheij m. Semin Radiat Oncol. 2023 Jul;33(3):287-297. doi: 10.1016/j.semradonc.2023.03.006. Semin Radiat Oncol. 2023. PMID: 37331783 Free article. Review.
Imaging radiotherapy-induced apoptosis.
Haimovitz-Friedman A, Yang TJ, Thin TH, Verheij M. Haimovitz-Friedman A, et al. Among authors: verheij m. Radiat Res. 2012 Apr;177(4):467-82. doi: 10.1667/rr2576.1. Epub 2012 Feb 21. Radiat Res. 2012. PMID: 22348249 Review.
Radiation Oncology in The Netherlands.
Slotman BJ, Vos P, Slot A, Keus R, Verheij M. Slotman BJ, et al. Among authors: verheij m. Int J Radiat Oncol Biol Phys. 2018 Jan 1;100(1):5-11. doi: 10.1016/j.ijrobp.2017.09.005. Int J Radiat Oncol Biol Phys. 2018. PMID: 29254780 No abstract available.
MR-Guided Radiotherapy: The Perfect Partner for Immunotherapy?
Hörner-Rieber J, Klüter S, Debus J, Adema G, Ansems M, Verheij M. Hörner-Rieber J, et al. Among authors: verheij m. Front Oncol. 2021 Feb 2;10:615697. doi: 10.3389/fonc.2020.615697. eCollection 2020. Front Oncol. 2021. PMID: 33604296 Free PMC article. Review.
Psilocybin for treating substance use disorders?
de Veen BT, Schellekens AF, Verheij MM, Homberg JR. de Veen BT, et al. Among authors: verheij mm. Expert Rev Neurother. 2017 Feb;17(2):203-212. doi: 10.1080/14737175.2016.1220834. Epub 2016 Aug 12. Expert Rev Neurother. 2017. PMID: 27684102 Review.
Towards Personalization in the Curative Treatment of Gastric Cancer.
Slagter AE, Vollebergh MA, Jansen EPM, van Sandick JW, Cats A, van Grieken NCT, Verheij M. Slagter AE, et al. Among authors: verheij m. Front Oncol. 2020 Nov 30;10:614907. doi: 10.3389/fonc.2020.614907. eCollection 2020. Front Oncol. 2020. PMID: 33330111 Free PMC article. Review.
Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19.
Roukens AHE, Pothast CR, König M, Huisman W, Dalebout T, Tak T, Azimi S, Kruize Y, Hagedoorn RS, Zlei M, Staal FJT, de Bie FJ, van Dongen JJM, Arbous SM, Zhang JLH, Verheij M, Prins C, van der Does AM, Hiemstra PS, de Vries JJC, Janse JJ, Roestenberg M, Myeni SK, Kikkert M, Yazdanbakhsh M, Heemskerk MHM, Smits HH, Jochems SP; in collaboration with BEAT-COVID group; in collaboration with COVID-19 LUMC group. Roukens AHE, et al. Among authors: verheij m. Nat Immunol. 2022 Jan;23(1):23-32. doi: 10.1038/s41590-021-01095-w. Epub 2021 Dec 22. Nat Immunol. 2022. PMID: 34937933
314 results